CSIMarket
 


Kempharm Inc  (KMPH)
Other Ticker:  
 

Kempharm Inc's Tangible Leverage Ratio

KMPH's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




KMPH Tangible Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity Change -28.8 % -24.05 % 44.21 % - -
Y / Y Total Liabilities Change 405.04 % 221.16 % -34.15 % -92.93 % -93.03 %
Tangible Leverage Ratio MRQ 0.27 0.25 0.03 0.04 0.04
Overall Ranking # # # # #
Seq. Tangible Equity Change -5.48 % -18.33 % -4.42 % -3.51 % 0.82 %
Seq. Total Liabilities Change 2.93 % 549.83 % -29.56 % 7.2 % -34.55 %



Tangible Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 2.93%, Tangible Leverage Ratio detoriated to 0.27, above company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry Kempharm Inc achieved lowest Tangible Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is KMPH Market Share?
Tangible Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Kempharm Inc's Tangible Equity $ 94 Millions Visit KMPH's Balance sheet
Kempharm Inc's Total Liabilities $ 26 Millions Visit KMPH's Balance sheet
Source of KMPH's Sales Visit KMPH's Sales by Geography


Cumulative Kempharm Inc's Tangible Leverage Ratio

KMPH's Tangible Leverage Ratio for the trailling 12 Months

KMPH Tangible Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity TTM Growth -28.8 % -24.05 % 44.21 % - -
Y / Y Total Liabilities TTM Growth 405.04 % 221.16 % -34.15 % -92.93 % -93.03 %
Tangible Leverage Ratio TTM 0.14 0.08 0.04 0.05 0.34
Total Ranking TTM # 311 # 217 # 101 # 137 # 758
Seq. Tangible Equity TTM Growth -5.48 % -18.33 % -4.42 % -3.51 % 0.82 %
Seq. Total Liabilities TTM Growth 2.93 % 549.83 % -29.56 % 7.2 % -34.55 %


TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 2.93%, Tangible Leverage Ratio improved to 0.14, below Kempharm Inc's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 113 other companies have achieved lower Tangible Leverage Ratio than Kempharm Inc. While total ranking remained unchanged compare to previous quarter at no. 311.

Explain Tangible Leverage Ratio?
What is KMPH Market Share?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 114
Healthcare Sector # 182
Within the Market # 311


TTM Tangible Leverage Ratio Statistics
High Average Low
1.92 0.43 0.05
(Jun 30 2021)  




Companies with similar Tangible Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Tangible Equity
Atreca inc   0.75 $ 72.388  Millions$ 96.253  Millions
Verastem Inc   0.74 $ 46.540  Millions$ 62.873  Millions
Theriva Biologics inc   0.73 $ 22.552  Millions$ 31.072  Millions
Lftd Partners Inc   0.72 $ 8.365  Millions$ 11.641  Millions
Ironwood Pharmaceuticals inc   0.72 $ 422.967  Millions$ 591.063  Millions
Yumanity Therapeutics Inc   0.71 $ 3.899  Millions$ 5.476  Millions
Tango Therapeutics Inc   0.70 $ 191.084  Millions$ 273.072  Millions
Bellerophon Therapeutics inc  0.70 $ 5.180  Millions$ 7.428  Millions
Equillium Inc   0.68 $ 19.125  Millions$ 28.160  Millions
Timber Pharmaceuticals inc   0.66 $ 5.073  Millions$ 7.633  Millions
Frequency Therapeutics Inc   0.66 $ 54.040  Millions$ 81.973  Millions
Revelation Biosciences Inc   0.66 $ 1.463  Millions$ 2.228  Millions
Igm Biosciences Inc   0.65 $ 212.761  Millions$ 328.175  Millions
Abvc Biopharma Inc   0.65 $ 3.682  Millions$ 5.693  Millions
Actinium Pharmaceuticals Inc   0.64 $ 45.561  Millions$ 71.255  Millions
Uniqure N v   0.61 $ 210.630  Millions$ 343.915  Millions
Syros Pharmaceuticals Inc   0.61 $ 78.938  Millions$ 129.171  Millions
Vallon Pharmaceuticals Inc   0.61 $ 2.110  Millions$ 3.459  Millions
Nature s Sunshine Products inc   0.61 $ 85.766  Millions$ 141.754  Millions
Alpine Immune Sciences Inc   0.60 $ 109.590  Millions$ 182.009  Millions
Iterum Therapeutics Plc  0.60 $ 18.089  Millions$ 30.401  Millions
Pds Biotechnology Corp  0.59 $ 27.828  Millions$ 47.059  Millions
Applied Molecular Transport Inc   0.59 $ 46.212  Millions$ 78.395  Millions
Macrogenics Inc   0.59 $ 72.389  Millions$ 122.958  Millions
Medavail Holdings Inc   0.57 $ 16.807  Millions$ 29.726  Millions
23andme Holding Co   0.55 $ 221.412  Millions$ 402.648  Millions
Scpharmaceuticals Inc   0.53 $ 16.582  Millions$ 31.110  Millions
Vaxxinity Inc   0.53 $ 42.699  Millions$ 80.261  Millions
Aptinyx Inc   0.52 $ 25.193  Millions$ 48.792  Millions
Aditxt Inc   0.52 $ 6.485  Millions$ 12.561  Millions

Date modified: 2022-11-12T19:26:45+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AIM's Profile

Stock Price

AIM's Financials

Business Description

Fundamentals

Charts & Quotes

AIM's News

Suppliers

AIM's Competitors

Customers & Markets

Economic Indicators

AIM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071